对中性粒细胞与淋巴细胞比值(Neutrophil to Lymphocyte Rate,NLR)联合红细胞分布宽度(Red blood cell distribution width,RDW)对于急诊老年脓毒症患者的诊疗价值进行分析与探讨。方法 2023年2月至2024年7月期间,招募180名老年脓毒症患...对中性粒细胞与淋巴细胞比值(Neutrophil to Lymphocyte Rate,NLR)联合红细胞分布宽度(Red blood cell distribution width,RDW)对于急诊老年脓毒症患者的诊疗价值进行分析与探讨。方法 2023年2月至2024年7月期间,招募180名老年脓毒症患者,依据其在急救过程中的休克状态,将其划分为非休克组(112名)与休克组(68名)。入院后随访观察30d,根据患者预后情况分为生存组(n=130)和死亡组(n=50)。对比不同组别患者NLR(中性粒细胞与淋巴细胞比值)、RDW(红细胞分布宽度)值以及NLR、RDW值与急性生理与慢性健康状况评估(Acute Physiology And Chronic Health Evaluation,APACHE Ⅱ)的相关性。结果 急诊时,NLR、RDW以及APACHEⅡ评分比较,休克组较非休克组明显更高(P<0.05);预后死亡组较生存组明显更高(P<0.05)。NLR、RDW单独预测患者死亡风险时,AUC、95%CI显著低于APACHEⅡ评分(P<0.05),二者联合应用时AUC、95%CI与APACHEⅡ评分相当(P>0.05)。结论 NLR、RDW能够较好的评估急诊老年脓毒症患者病情,能够较为准确的预测患者预后情况,二者联合应用的预后评估准确性与APACHEⅡ评分相近。展开更多
目的:本研究旨在探讨RPR水平与多发性骨髓瘤(MM)患者预后的预测价值。方法:我们回顾性分析了161例新诊断的MM患者,收集患者临床资料,根据MM的预后确定RPR的最佳截断值,将MM患者分为高RPR组和低RPR组,比较两组之间临床资料的差异性,分析...目的:本研究旨在探讨RPR水平与多发性骨髓瘤(MM)患者预后的预测价值。方法:我们回顾性分析了161例新诊断的MM患者,收集患者临床资料,根据MM的预后确定RPR的最佳截断值,将MM患者分为高RPR组和低RPR组,比较两组之间临床资料的差异性,分析RPR对MM患者预后的影响。结果:RPR最佳截断值为0.115时预测价值最高,高RPR组和低RPR组总生存期(OS)的中位数均未达到,Kaplan-Meier生存分析显示两者间差异具有统计学意义(P 0.115、肌酐 > 177 umol/L是OS的独立预后因素;RPR > 0.115是PFS的独立预后因素(P Objective: The aim of this study was to investigate the prognosis value of RPR of MM patients. Methods: We retrospectively analysed 161 newly diagnosed MM patients, collected patients’ clinical data. According to the best cut off value of RPR on the prognosis of MM, they were divided into high RPR group and low RPR group. The differences in clinical data between the two groups were compared and the influence of RPR on the prognosis of MM was analyzed. Results: The best RPR cut off value was 0.115 when the predictive value was the highest. The median overall survival (OS) was not reached in both the high and low RPR groups, and Kaplan-Meier survival analysis showed that the difference was statistically significant (P 0.115, and creatinine > 177 umol/L were independent prognostic factors for OS;RPR > 0.115 was an independent prognostic factor for PFS (P < 0.05). Conclusion: RPR is a practical and validated prognostic marker for newly diagnosed MM patients, and high RPR is an independent poor prognostic factor for OS and PFS in MM patients.展开更多
慢性阻塞性肺疾病(COPD)是一种常见的慢性呼吸系统疾病,其预后受到多种因素的影响。对于COPD预后的新型生物标志物的鉴定,增强疾病稳定和急性加重患者的临床决策,受到了强烈的关注。虽然已经提出了几种气道和循环炎症生物标志物,但新出...慢性阻塞性肺疾病(COPD)是一种常见的慢性呼吸系统疾病,其预后受到多种因素的影响。对于COPD预后的新型生物标志物的鉴定,增强疾病稳定和急性加重患者的临床决策,受到了强烈的关注。虽然已经提出了几种气道和循环炎症生物标志物,但新出现的证据也表明常规血液学参数(例如红细胞分布宽度(RDW))的潜在作用。RDW作为一种简单易得的血液学指标,近年来被发现与COPD患者的预后密切相关。本综述旨在综合分析RDW与COPD患者预后的相关性,探讨其在评估COPD患者病情严重程度、死亡率、急性加重风险以及指导临床治疗等方面的价值。通过对已发表中英文研究的归纳总结,发现RDW在COPD患者中具有重要的预后评估意义,但仍需要进一步的临床研究来明确其具体的作用机制和应用价值。Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease, and its prognosis is affected by many factors. The search for novel biomarkers to predict the prognosis of COPD and improve clinical decision-making in both stable and acute exacerbation phases has attracted significant attention. While several biomarkers related to airway and circulatory inflammation have been proposed, emerging evidence also points to the potential value of conventional hematological parameters, such as the red blood cell distribution width (RDW). As a simple and readily accessible hematological index, RDW has been closely associated with the prognosis of COPD patients in recent years. This review aims to comprehensively analyze the correlation between RDW and the prognosis of COPD patients and explore its utility in assessing the severity, mortality, and acute exacerbation risk, and guiding clinical treatment in these patients. A comprehensive summary of published Chinese and English studies indicates that RDW has important prognostic significance in COPD patients. However, further clinical studies are still needed to clarify its specific mechanism and application value.展开更多
文摘对中性粒细胞与淋巴细胞比值(Neutrophil to Lymphocyte Rate,NLR)联合红细胞分布宽度(Red blood cell distribution width,RDW)对于急诊老年脓毒症患者的诊疗价值进行分析与探讨。方法 2023年2月至2024年7月期间,招募180名老年脓毒症患者,依据其在急救过程中的休克状态,将其划分为非休克组(112名)与休克组(68名)。入院后随访观察30d,根据患者预后情况分为生存组(n=130)和死亡组(n=50)。对比不同组别患者NLR(中性粒细胞与淋巴细胞比值)、RDW(红细胞分布宽度)值以及NLR、RDW值与急性生理与慢性健康状况评估(Acute Physiology And Chronic Health Evaluation,APACHE Ⅱ)的相关性。结果 急诊时,NLR、RDW以及APACHEⅡ评分比较,休克组较非休克组明显更高(P<0.05);预后死亡组较生存组明显更高(P<0.05)。NLR、RDW单独预测患者死亡风险时,AUC、95%CI显著低于APACHEⅡ评分(P<0.05),二者联合应用时AUC、95%CI与APACHEⅡ评分相当(P>0.05)。结论 NLR、RDW能够较好的评估急诊老年脓毒症患者病情,能够较为准确的预测患者预后情况,二者联合应用的预后评估准确性与APACHEⅡ评分相近。
文摘目的:本研究旨在探讨RPR水平与多发性骨髓瘤(MM)患者预后的预测价值。方法:我们回顾性分析了161例新诊断的MM患者,收集患者临床资料,根据MM的预后确定RPR的最佳截断值,将MM患者分为高RPR组和低RPR组,比较两组之间临床资料的差异性,分析RPR对MM患者预后的影响。结果:RPR最佳截断值为0.115时预测价值最高,高RPR组和低RPR组总生存期(OS)的中位数均未达到,Kaplan-Meier生存分析显示两者间差异具有统计学意义(P 0.115、肌酐 > 177 umol/L是OS的独立预后因素;RPR > 0.115是PFS的独立预后因素(P Objective: The aim of this study was to investigate the prognosis value of RPR of MM patients. Methods: We retrospectively analysed 161 newly diagnosed MM patients, collected patients’ clinical data. According to the best cut off value of RPR on the prognosis of MM, they were divided into high RPR group and low RPR group. The differences in clinical data between the two groups were compared and the influence of RPR on the prognosis of MM was analyzed. Results: The best RPR cut off value was 0.115 when the predictive value was the highest. The median overall survival (OS) was not reached in both the high and low RPR groups, and Kaplan-Meier survival analysis showed that the difference was statistically significant (P 0.115, and creatinine > 177 umol/L were independent prognostic factors for OS;RPR > 0.115 was an independent prognostic factor for PFS (P < 0.05). Conclusion: RPR is a practical and validated prognostic marker for newly diagnosed MM patients, and high RPR is an independent poor prognostic factor for OS and PFS in MM patients.
文摘慢性阻塞性肺疾病(COPD)是一种常见的慢性呼吸系统疾病,其预后受到多种因素的影响。对于COPD预后的新型生物标志物的鉴定,增强疾病稳定和急性加重患者的临床决策,受到了强烈的关注。虽然已经提出了几种气道和循环炎症生物标志物,但新出现的证据也表明常规血液学参数(例如红细胞分布宽度(RDW))的潜在作用。RDW作为一种简单易得的血液学指标,近年来被发现与COPD患者的预后密切相关。本综述旨在综合分析RDW与COPD患者预后的相关性,探讨其在评估COPD患者病情严重程度、死亡率、急性加重风险以及指导临床治疗等方面的价值。通过对已发表中英文研究的归纳总结,发现RDW在COPD患者中具有重要的预后评估意义,但仍需要进一步的临床研究来明确其具体的作用机制和应用价值。Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease, and its prognosis is affected by many factors. The search for novel biomarkers to predict the prognosis of COPD and improve clinical decision-making in both stable and acute exacerbation phases has attracted significant attention. While several biomarkers related to airway and circulatory inflammation have been proposed, emerging evidence also points to the potential value of conventional hematological parameters, such as the red blood cell distribution width (RDW). As a simple and readily accessible hematological index, RDW has been closely associated with the prognosis of COPD patients in recent years. This review aims to comprehensively analyze the correlation between RDW and the prognosis of COPD patients and explore its utility in assessing the severity, mortality, and acute exacerbation risk, and guiding clinical treatment in these patients. A comprehensive summary of published Chinese and English studies indicates that RDW has important prognostic significance in COPD patients. However, further clinical studies are still needed to clarify its specific mechanism and application value.
